Professor, Internal Medicine, University of Kentucky College of Medicine
Nephrology
Dr. Thomas H. Waid, MD
|
|
Give Review
Thomas Waid is an expert in the field of Nephrology. He went to University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63/72 in Research/PrimaryCare. Thomas H. Waid, MD is a published doctor and has 28 publications published. The lastest was: 'Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.' He is registered with Medicare.
Publications
- Mycophenolate mofetil-based immunosuppression with sirolimus in Renal transplantation: a randomized, controlled Spare-the-Nephron trial.
- Long-term survival following simultaneous Kidney-pancreas transplantation versus Kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
- Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for Chronic renal allograft failure.
- Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
- Recipient outcome following living donor Kidney transplantation using Kidneys procured laparoscopically.
- Impact of acute rejection episodes on long-term graft survival following simultaneous Kidney-pancreas transplantation.
- Immunosuppression in Renal-transplantation does not increase the incidence of native Renal-cancer.
- Transplantation of pediatric en bloc cadaver Kidneys into adult recipients: a single-center experience.
- Pancreas transplantation: current status and experience at the University of Kentucky.
- Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary Renal allograft recipients: a report of the Neoral Study Group.
- Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary Renal allograft recipients. Neoral Study Group.
- The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary Renal allograft recipients. The Neoral Stu...
- The pharmacokinetics of a microemulsion formulation of cyclosporine in primary Renal allograft recipients. The Neoral Study Group.
- Comparison of T10Bg.1A-31 and OKT3 in treating acute Renal allograft rejection.
- Cytomegalovirus hyperimmune globulin for CMV Disease refractory to ganciclovir in renal transplantation.
- Renal vein thrombosis presenting as Renal mass.
- T10B9 (MEDI-500) mediated immunosuppression: studies on the mechanism of action.
- Treatment of acute rejection with anti-T-cell antigen receptor complex alpha beta (T10B9.1A-31) or anti-CD3 (OKT3) monoclonal antibody: results of a prospective random...
- Treatment of acute cellular rejection with T10B9.1A-31 or OKT3 in Renal allograft recipients.
- Direct neural inhibition of insulin secretion in response to systemic hypoglycemia.
- Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.
- Treatment of Renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial.
- T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.
- Conversion from cyclosporine to tacrolimus in patients at risk for Chronic renal allograft failure: 60-month results of the CRAF Study.
- T10B9 action: the effect of anti-T-cell antibody mitogenicity and graft rejection on the first dose cytokine response.
- Treatment of acute cellular Kidney allograft rejection with T10B9.1A-31A anti T-cell monoclonal antibody.
- T10B9.1A-31 anti-T-cell monoclonal antibody: preclinical studies and clinical treatment of solid organ allograft rejection.
Schools
University of Kentucky College of Medicine
University Of Kentucky
Procedures Preformed
- Biopsy
- Dialysis Access Procedures
- Hemodialysis
- Kidney Stones Treatment
- View All
Conditions Treated
- Anemia
- Chronic Kidney Diseases
- Diabetes
- Electrolyte Disorders
- View All
Doctors Specialties
- Internal Medicine
- Nephrology
Accepted Insurances
Education
-
University of Kentucky College of Medicine
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1265446744 | |
| NPPES Provider LastName | WAID | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Nephrology | |
| Total Claim Count | 3924.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265446744 |
| Last Name Of The Provider | WAID |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Jeremy L. Warner, MD |
|
|
Dr. Adrian A. Fulmer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Baher M. Alhomsi, MD |
|
Dr. William B. Caudill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Subodh Pandey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly E. Wingerter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhammad Rafiuddin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee W. Ricketts II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory A. Hood, MD |
|
|
Dr. Mohamad B. Al-Abed, MD |
|
|
Dr. Megan M. Robinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vicki L. Hawes, MD |
|
|
Dr. Stuart C. Jennings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ghassan Shakhashiro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles C. Stafford, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rezkalla Butros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amr Mohamed, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Syed A. Hussain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Amanda K. Gaddis, APRN |
|
|
Dr. Jonathan C. Webb, MD |
|
|
Dr. Vijaya Y. Samadi, MD
This Doctor is OpenDoctor Recommended.
|